arrow
M

María Sereno

hospital puerta de hierro-majadahonda
H指数:23
被引数:1,798

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Data of First-Line Cemiplimab Monotherapy for Metastatic Non-Small Cell Lung Cancer (NSCLC) with PD-L1 Expression ≥ 50%: A National Spanish Multicentric Cohort (CEMI-SPA Study)

真实世界数据:PD-L1表达≥50%的转移性非小细胞肺癌(NSCLC)患者的一线西米普利单抗单药治疗——西班牙国家多中心队列(CEMI-SPA研究)

2025-11-180
OAAI
Surgical Results after Neoadjuvant Nivolumab and Platinum-based Chemotherapy for Resectable Lung Cancer. A Multicentre European Real Clinical Practice Analysis

新辅助纳武利尤单抗联合铂类化疗治疗可切除肺癌的手术结果。一项多中心欧洲真实临床实践分析

2025-10-010
PRE
LUDICAS: sexual dysfunction in patients with lung cancer, a multicenter cross-sectional study

LUDICAS:肺癌患者性功能障碍,一项多中心横断面研究

2025-04-010
OAAI
Randomized clinical trial in cancer patients shows immune metabolic effects exerted by formulated bioactive phenolic diterpenes with potential clinical benefits
2025-02-170
OAAI
Update on the analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/ PD-L1

关于化疗联合抗PD-1/PD-L1新辅助治疗中可操作性参数变化的分析进展

2024-09-010
PRE
Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B
2023-11-019
OAAI
Original Research Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor-positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment
2021-05-0124
OAAI
High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

具有ROS1重排的晚期肺癌患者血栓形成的高风险

2020-12-0117
PREAI
Clinical Activity of Afatinib in Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Spanish Retrospective Multicenter Study

Afatinib在非小细胞肺癌患者中具有罕见EGFR突变的临床活性: 西班牙回顾性多中心研究

2020-09-0118
PREAI
Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer
2020-01-0112
OAAI
Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer
2018-03-2133
OAAI